Immunocore (IMCR)
undefined
undefined%
At close: undefined
29.87
0.00%
After-hours Jan 06, 2025, 04:00 PM EST

Immunocore Revenue Breakdown

Quarter Sep 30, 2024
Product Revenue 80.25M
Product Revenue Growth n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021
Rest Of World Revenue 3.60M 35.49M 3.01M
Rest Of World Revenue Growth -89.86% +1079.07% n/a
Europe Revenue 67.63M 871.00K n/a
Europe Revenue Growth +7664.41% n/a n/a
United States Revenue 169.79M n/a n/a
United States Revenue Growth n/a n/a n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
Selling, General, and Administrative Revenue 35.53M 38.64M 39.29M 57.13M 13.37M 45.60M 41.16M 43.14M 25.88M 24.51M 20.11M 24.37M 20.05M 23.80M 20.18M 14.17M 9.71M 12.25M 9.61M 8.57M
Selling, General, and Administrative Revenue Growth -8.04% -1.65% -31.23% +327.39% -70.69% +10.78% -4.59% +66.68% +5.59% +21.91% -17.48% +21.54% -15.77% +17.92% +42.43% +45.88% -20.70% +27.54% +12.05% n/a
Research and Development Revenue 52.77M 51.07M 57.46M 74.65M 38.53M 36.43M 35.16M 27.14M 23.30M 20.15M 18.58M 20.07M 16.80M 16.47M 19.89M 17.24M 20.41M 16.38M 20.78M 24.58M
Research and Development Revenue Growth +3.32% -11.12% -23.03% +93.74% +5.77% +3.59% +29.58% +16.47% +15.64% +8.44% -7.43% +19.49% +1.99% -17.17% +15.32% -15.51% +24.61% -21.18% -15.45% n/a
Sales and Marketing Revenue 11.62M 13.05M n/a 17.20M n/a n/a n/a n/a 7.47M 8.19M n/a n/a 5.08M 4.70M n/a n/a n/a n/a n/a 24.58M
Sales and Marketing Revenue Growth -10.96% n/a -100.00% n/a n/a n/a n/a -100.00% -8.78% n/a n/a -100.00% +8.14% n/a n/a n/a n/a n/a -100.00% n/a